GRAND PHARMA (00512) was awarded HKD 800 million of regular financing.

17:56 19/03/2026

Yuan Da Medicine (00512) announced that Yuan Da Medicine (Hong Kong) Limited (a wholly-owned subsidiary of the Company) as the borrower, the Company and several of its subsidiaries as guarantors, and several banks as lenders have signed a financing credit agreement for HK$800 million. The financing period is 36 months from the effective date of the financing extension.

GRAND PHARMA (00512) announced that GRAND PHARMA (Hong Kong) Limited (a wholly-owned subsidiary of the company) as the borrower, the company and several of its subsidiaries as guarantors, and several banks as lenders have signed a financing credit agreement for HK$800 million. The financing period is 36 months from the effective date of the extension of the financing.

PAX GLOBAL (00327) announced its performance for the year 2025, with a net profit attributable to shareholders of HK$753.6 million, representing a year-on-year increase of 5.6%.

J.P. Morgan reduces its stake in FLAT GLASS (06865) by 24,370 shares at a price of approximately HK$9.79 per share.

CATHAY GP HLDGS (01981) announces good profit, expecting comprehensive profit for 2025 to exceed 300 million yuan, a significant increase year-on-year.

PAX GLOBAL (00327) announced its performance for the year 2025, with a net profit attributable to shareholders of HK$753.6 million, representing a year-on-year increase of 5.6%.

J.P. Morgan reduces its stake in FLAT GLASS (06865) by 24,370 shares at a price of approximately HK$9.79 per share.

CATHAY GP HLDGS (01981) announces good profit, expecting comprehensive profit for 2025 to exceed 300 million yuan, a significant increase year-on-year.